Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Pralidoxime chloride |
Is a |
False |
Pralidoxime (substance) |
Inferred relationship |
Some |
|
Pralidoxime adverse reaction |
Causative agent (attribute) |
True |
Pralidoxime (substance) |
Inferred relationship |
Some |
1 |
Allergy to pralidoxime (finding) |
Causative agent (attribute) |
False |
Pralidoxime (substance) |
Inferred relationship |
Some |
|
Pralidoxime mesylate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pralidoxime (substance) |
Inferred relationship |
Some |
|
mésylate de pralidoxime 200 mg/mL, ampoule de 5 mL pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pralidoxime (substance) |
Inferred relationship |
Some |
|
Product containing pralidoxime (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pralidoxime (substance) |
Inferred relationship |
Some |
1 |
Pralidoxime chloride 1g/20mL powder for injection 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pralidoxime (substance) |
Inferred relationship |
Some |
|
Product containing atropine and pralidoxime (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pralidoxime (substance) |
Inferred relationship |
Some |
2 |
Atropine/pralidoxime two auto-injectors injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pralidoxime (substance) |
Inferred relationship |
Some |
|
Atropine/pralidoxime single auto-injector solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pralidoxime (substance) |
Inferred relationship |
Some |
|
Atropine 2.1mg/pralidoxime 600mg single auto-injector solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pralidoxime (substance) |
Inferred relationship |
Some |
|
Atropine 2mg/pralidoxime 600mg two auto-injectors solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pralidoxime (substance) |
Inferred relationship |
Some |
|
Pralidoxime mesilate (substance) |
Is a |
False |
Pralidoxime (substance) |
Inferred relationship |
Some |
|
Allergy to pralidoxime (finding) |
Causative agent (attribute) |
True |
Pralidoxime (substance) |
Inferred relationship |
Some |
1 |
Pralidoxime methyl sulfate (substance) |
Is a |
False |
Pralidoxime (substance) |
Inferred relationship |
Some |
|
Pralidoxime methyl sulfate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Pralidoxime (substance) |
Inferred relationship |
Some |
|
Pralidoxime mesilate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Pralidoxime (substance) |
Inferred relationship |
Some |
|
Pralidoxime chloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Pralidoxime (substance) |
Inferred relationship |
Some |
|
Product containing atropine and pralidoxime in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pralidoxime (substance) |
Inferred relationship |
Some |
2 |
Pralidoxime-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pralidoxime (substance) |
Inferred relationship |
Some |
1 |
Product containing only atropine and pralidoxime (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pralidoxime (substance) |
Inferred relationship |
Some |
2 |
Product containing only pralidoxime (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pralidoxime (substance) |
Inferred relationship |
Some |
1 |
Product containing only atropine and pralidoxime in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pralidoxime (substance) |
Inferred relationship |
Some |
2 |
Product containing only pralidoxime in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pralidoxime (substance) |
Inferred relationship |
Some |
1 |
Pralidoxime iodide (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Pralidoxime (substance) |
Inferred relationship |
Some |
|